You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis
|
---|---|
Published in |
Frontiers in oncology, December 2021
|
DOI | 10.3389/fonc.2021.769068 |
Pubmed ID | |
Authors |
Naoki Matsumura, Kazutoshi Fujita, Mitsuhisa Nishimoto, Yutaka Yamamoto, Ken Kuwahara, Yasuharu Nagai, Takafumi Minami, Yuji Hatanaka, Masahiro Nozawa, Yasuhiro Morimoto, Hideo Tahara, Shigeya Uejima, Atsunobu Esa, Akihide Hirayama, Kazuhiro Yoshimura, Hirotsugu Uemura |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 67% |
Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 1 | 11% |
Student > Ph. D. Student | 1 | 11% |
Student > Bachelor | 1 | 11% |
Lecturer | 1 | 11% |
Other | 1 | 11% |
Other | 0 | 0% |
Unknown | 4 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 2 | 22% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 22% |
Unspecified | 1 | 11% |
Unknown | 4 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2022.
All research outputs
#16,734,944
of 25,392,582 outputs
Outputs from Frontiers in oncology
#6,624
of 22,436 outputs
Outputs of similar age
#286,025
of 513,670 outputs
Outputs of similar age from Frontiers in oncology
#372
of 1,353 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,670 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,353 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.